Upadacitinib and Pain in RA, PsA - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 4 min

Share

Original Source(s)

Upadacitinib and Pain in RA, PsA

  • by Kathryn Wighton

  • February 25, 2026

Related Content

Combined Internet-Based Cognitive Behavioral Therapy and Face-to-Face Physiotherapy in Primary Health Care for Chronic Widespread Pain: Randomized Controlled Trial

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

Editorial: Characterising the functional heterogeneity of synovial macrophages